SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • February 15th, 2022 • Corcept Therapeutics Inc • Pharmaceutical preparations • California
THIS SEVERANCE AND CHANGE IN CONTROL AGREEMENT (“Agreement”) dated as of February 9, 2022 (the “Effective Date”) is entered into by and between William Guyer, Chief Development Officer (“OFFICER”) and Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”).
